The nitric oxide synthase family and left ventricular diastolic function

Circulation Journal

Volumn 74, Issue 12, 2010, Pages 2556-2557

  Takeishi, Yasuchika ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; ANGIOTENSIN RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; HYDRALAZINE; INDUCIBLE NITRIC OXIDE SYNTHASE; KETAMINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OLMESARTAN; TRANSFORMING GROWTH FACTOR BETA; XYLAZINE;

CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DILATATION; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; ENZYME ACTIVITY; FEASIBILITY STUDY; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART RATE VARIABILITY; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LUNG WEIGHT; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL RATE;

ANIMALS; ECHOCARDIOGRAPHY; HOMEOSTASIS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 78649717194     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-1069     Document Type: Editorial

References (9)

1. Tsutsui M, Shimokawa H, Otsuji Y, Ueta Y, Sasaguri Y, Yanagihara N. Nitric oxide synthases and cardiovascular diseases: Insights from genetically modified mice. Circ J 2009; 73: 986-993.
2. Morishita T, Tsutsui M, Shimokawa H, Sabana K, Tasaki H, Suda O, et al. Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. Proc Natl Acad Sci USA 2005; 102: 10616-10621.
3. Nakata S, Tsutsui M, Shimokawa H, Suda O, Morishita T, Shibata K, et al. Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms. Circulation 2008; 117: 2211-2223.
4. Shibata K, Yatera Y, Furuno Y, Sabanai K, Morisada N, Nakata S, et al. Spontaneous development of left ventricular hypertrophy and diastolic dysfunction in mice lacking all nitric oxide synthases. Circ J 2010; 74: 2681-2692.
5. Stypmann J. Doppler ultrasound in mice. Echocardiography 2007; 24: 97-112.
6. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259.
7. Kindermann M, Reil JC, Pieske B, van Veldhuisen DJ, Böhm M. Heart failure with normal left ventricular ejection fraction: What is the evidence? Trends Cardiovasc Med 2008; 18: 280-292.
8. Paulus WJ. Novel strategies in diastolic heart failure. Heart 2010; 96: 1147-1153.
9. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008; 359: 2456-2467.